|
V78042
|
Anti-Mouse CD19 Antibody (1D3) |
|
Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor. |
|
V78686
|
CD19 CAR circRNA |
|
CD19 CAR circRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19). |
|
V78687
|
CD19 car circRNA-LNP |
|
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, which is suitable for detection of RNA delivery, translation efficiency, cell viability, etc. |
|
V78689
|
CD19 car mRNA-LNP |
|
CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. |
|
V78688
|
CD19 CARmRNA |
|
CD19 CAR mRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19). |
|
V74757
|
Duvortuxizumab (MGD 011) |
1831098-91-9 |
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E. |
|
V79307
|
Englumafusp alfa (CD19-4-1BBL; RO7227166; RG6076) |
|
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct consisting of a CD19-specific antibody domain fused to the trimerizing ectodomain of human 41BBL. |
|
V51117
|
Loncastuximab (RB-4v1.2) |
1875032-68-0 |
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody (mAb). |
|
V74758
|
MDX-1342 |
1646327-65-2 |
MDX-1342 is a fully human monoclonal antibody (mAb) (HuMAb) targeting the CD19 membrane receptor. |
|
V74756
|
Obexelimab (XmAb5871) |
1690307-05-1 |
Obexelimab (XmAb5871) is a humanized anti-CD19 antibody Fc-engineered to increase affinity for FcγRIIb. |
|
V74760
|
Taplitumomab paptox |
235428-87-2 |
Taplitumomab paptox is an anti-CD19 monoclonal antibody (mAb). |
|
V74759
|
Tisagenlecleucel (CTL019) |
1823078-37-0 |
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy. |